clinical trial · NCT07218783
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
CataractGlaucomaOcular HypertensionBimatoprost Implant SystemSpyGlass IOLTimolol Maleate Ophthalmic Solution, 0.5%Commercial IOL
brief summary
This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
started
Oct 15, 2025
primary completion
Mar 31, 2029
completion
Mar 31, 2031
last updated
Oct 20, 2025
official title
A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol